Clinical Studies in Process                                                                              Sitemap

Principal Investigator, Merck & Company, Inc.

“MK 0653A, Protocol 107-00:

A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients with Metabolic Syndrome and Hypercholesterolemia at High Risk for Coronary Heart Disease”.

Principal Investigator, Eli Lilly & Company, Inc.
 

“B3D-US-GHCQ: Direct Assessment of Non-Vertebral Fractures in Community Experience (DANCE)”.